Kaloyannidis, P., Hertzberg, M., Webb, K., Zomas, A., Schrover, R., Hurst, M., . . . Connors, J. M. (2019). Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation. Br J Haematol.

Kaloyannidis, Panayotis, Mark Hertzberg, Kate Webb, Athanasios Zomas, Rudolf Schrover, Michael Hurst, Ian Jacob, Thalia Nikoglou, a Joseph M. Connors. "Brentuximab Vedotin for the Treatment of Patients With Relapsed or Refractory Hodgkin Lymphoma After Autologous Stem Cell Transplantation." Br J Haematol 2019.

Kaloyannidis, Panayotis, et al. "Brentuximab Vedotin for the Treatment of Patients With Relapsed or Refractory Hodgkin Lymphoma After Autologous Stem Cell Transplantation." Br J Haematol 2019.